Hosted on MSN14d
UnitedHealth, employer of slain exec Brian Thompson, found to have overcharged some cancer patients for drugs by over 1,000%
UnitedHealth Group is charging patients a markup for key life-saving ... According to the FTC report, UnitedHealth’s OptumRx, along with Cigna’s Express Scripts and CVS Caremark Rx, were able to ...
Cigna taking steps to lower out-of-pocket cost of prescription drugs
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
United Health Lawsuit Named Among FTC's Biggest Wins
The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.
Newsweek on MSN13d
UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims
The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...
How UnitedHealth and Rivals Made $7.3 Billion Marking Up Drugs: FTC
The Federal Trade Commission said three top pharmacy suppliers made profits of 7,700 percent on a lifesaving hypertension ...
Campus Safety Magazine13d
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging
FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...
'It's Out of Control': UnitedHealth Group and Peers Charged Americans 1000% More for Drugs
FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.
News Nation on MSN12d
UnitedHealth marked up lifesaving drugs as much as 1,000%: FTC
Between 2017 and 2022, UnitedHealth Group’s Optum, Cigna’s Express Scripts and CVS Health’s CVS Caremark marked up their ...
The FTC Finds United Health’s OptumRX Is Engaged In Widespread Price Gouging
The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...
Becker's Hospital Review7d
Big 3 PBM formularies favor private-label biosimilars
Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.
UnitedHealth’s Revenues Rise, in First Earnings Report Since C.E.O.’s Killing
But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...
Yahoo Finance16d
FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down
Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth ... Cigna’s Express Scripts, and UnitedHealth’s OptumRx — imposed markups of hundreds to ...